What does DR. GERD FABRE do?

DR. GERD FABRE is a specialist medical practice in Herent. Private Limited, started on 11 February 2008, 1 establishment.

What is the address of DR. GERD FABRE?

The registered office of DR. GERD FABRE is located at Terbankstraat 12, 3020 Herent.

Is DR. GERD FABRE still active?

Yes. According to the CBE (15 November 2026) DR. GERD FABRE is active, legal situation “Normale toestand”, started on 11 February 2008.

Is DR. GERD FABRE registered on Peppol?

Yes, DR. GERD FABRE is registered on the Peppol network with ID 0208:0895712153.

What is the enterprise number of DR. GERD FABRE?

The enterprise number of DR. GERD FABRE is BE0895712153.

When was DR. GERD FABRE founded?

DR. GERD FABRE was founded on 11 February 2008.

Who are the directors of DR. GERD FABRE?

According to the 2025 annual accounts, the directors of DR. GERD FABRE are: Gerd Fabre.

Is DR. GERD FABRE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 February 2008; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 events from the Belgian Official Gazette processed.

How much profit did DR. GERD FABRE make in 2025?

DR. GERD FABRE posted a profit after taxes of € 397,576 in financial year 2025.

What is the revenue of DR. GERD FABRE?

As a small company, DR. GERD FABRE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 724,041.

DR. GERD FABRE (Private Limited) - Herent - BE0895712153

Dossier DR. GERD FABRE, printed on 15 November 2026 from databakkes.be/en/0895712153/dr-gerd-fabre. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. GERD FABRE from Herent, company number BE0895712153, closed financial year 2025 with a result of € 397,576 after tax. For that financial year DR. GERD FABRE recorded a gross margin of € 724,041 and equity of € 3.6 million. Compared with financial year 2024, the result moved from € 623,854 to € 397,576. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 26, 2026.

What it is worth Growing

€ 3.6 million

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 397,576

▼ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1 million

▼ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 3.6 million.

People and assets in 2025

Vehicles and equipment

€ 67,321

▲ € 55,985 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go

€ 272,077

▼ 11% vs 2024

€ 62,652 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 1,333

▼ 62% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 81,225

▼ 40% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 718,506 Gross margin 2022: € 718,506 First fiscal year in the series	€ 788,406 Gross margin 2023: € 788,406 ▲ 10% vs 2022 (€ 718,506) Favourable step	€ 1,008,843 Gross margin 2024: € 1,008,843 ▲ 28% vs 2023 (€ 788,406) Favourable step	€ 724,041 Gross margin 2025: € 724,041 ▼ 28% vs 2024 (€ 1,008,843) Unfavourable step	▼ 28%
Profit after taxes	€ 385,919 Profit after taxes 2022: € 385,919 First fiscal year in the series	€ 465,410 Profit after taxes 2023: € 465,410 ▲ 21% vs 2022 (€ 385,919) Favourable step	€ 623,854 Profit after taxes 2024: € 623,854 ▲ 34% vs 2023 (€ 465,410) Favourable step	€ 397,576 Profit after taxes 2025: € 397,576 ▼ 36% vs 2024 (€ 623,854) Unfavourable step	▼ 36%
Equity	€ 2,515,289 Equity 2022: € 2,515,289 First fiscal year in the series	€ 2,980,700 Equity 2023: € 2,980,700 ▲ 19% vs 2022 (€ 2,515,289) Favourable step	€ 3,220,553 Equity 2024: € 3,220,553 ▲ 8% vs 2023 (€ 2,980,700) Favourable step	€ 3,618,129 Equity 2025: € 3,618,129 ▲ 12% vs 2024 (€ 3,220,553) Favourable step	▲ 12%
Total debts	€ 1,305,557 Total debts 2022: € 1,305,557 First fiscal year in the series	€ 946,456 Total debts 2023: € 946,456 ▼ 28% vs 2022 (€ 1,305,557) Favourable step	€ 1,228,257 Total debts 2024: € 1,228,257 ▲ 30% vs 2023 (€ 946,456) Unfavourable step	€ 723,668 Total debts 2025: € 723,668 ▼ 41% vs 2024 (€ 1,228,257) Favourable step	▼ 41%
Cash	€ 405,685 Cash 2022: € 405,685 First fiscal year in the series	€ 576,264 Cash 2023: € 576,264 ▲ 42% vs 2022 (€ 405,685) Favourable step	€ 1,213,962 Cash 2024: € 1,213,962 ▲ 111% vs 2023 (€ 576,264) Favourable step	€ 1,041,693 Cash 2025: € 1,041,693 ▼ 14% vs 2024 (€ 1,213,962) Unfavourable step	▼ 14%
Land & buildings	€ 2,603,123 Land & buildings 2022: € 2,603,123 First fiscal year in the series	€ 2,551,497 Land & buildings 2023: € 2,551,497 ▼ 2% vs 2022 (€ 2,603,123) Unchanged	€ 2,447,033 Land & buildings 2024: € 2,447,033 ▼ 4% vs 2023 (€ 2,551,497) Unchanged	€ 2,331,108 Land & buildings 2025: € 2,331,108 ▼ 5% vs 2024 (€ 2,447,033) Unchanged	▼ 5%
Retained profit	€ 2,502,889 Retained profit 2022: € 2,502,889 First fiscal year in the series	€ 2,968,300 Retained profit 2023: € 2,968,300 ▲ 19% vs 2022 (€ 2,502,889) Favourable step	€ 3,208,153 Retained profit 2024: € 3,208,153 ▲ 8% vs 2023 (€ 2,968,300) Favourable step	€ 3,605,729 Retained profit 2025: € 3,605,729 ▲ 12% vs 2024 (€ 3,208,153) Favourable step	▲ 12%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 384,000 Dividend 2024: € 384,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 384,000) Unchanged	▼ 100%
Bank debt	€ 511,741 Bank debt 2022: € 511,741 First fiscal year in the series	€ 413,389 Bank debt 2023: € 413,389 ▼ 19% vs 2022 (€ 511,741) Favourable step	€ 304,789 Bank debt 2024: € 304,789 ▼ 26% vs 2023 (€ 413,389) Favourable step	€ 272,077 Bank debt 2025: € 272,077 ▼ 11% vs 2024 (€ 304,789) Favourable step	▼ 11%
Balance sheet total	€ 3,820,846 Balance sheet total 2022: € 3,820,846 First fiscal year in the series	€ 3,927,155 Balance sheet total 2023: € 3,927,155 ▲ 3% vs 2022 (€ 3,820,846) Unchanged	€ 4,448,810 Balance sheet total 2024: € 4,448,810 ▲ 13% vs 2023 (€ 3,927,155) Unchanged	€ 4,341,797 Balance sheet total 2025: € 4,341,797 ▼ 2% vs 2024 (€ 4,448,810) Unchanged	▼ 2%

By gross margin, DR. GERD FABRE ranks 2nd of 32 companies with main activity “Activiteiten van medisch specialisten” in Herent that publish figures (fiscal year 2025).

Key figures of DR. GERD FABRE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

Ask about DR. GERD FABRE the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to DR. GERD FABRE?

What happened at DR. GERD FABRE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 26, 2026 New annual accounts for financial year 2025: profit of € 397,576 (▼ 36% vs 2024). Source: NBB ↗
Jul 22, 2014 Capital increase of € 860,000, published in the Gazette. Source: Staatsblad ↗
Feb 25, 2008 Incorporation, published in the Gazette. Source: Staatsblad ↗
2008 Gerd Fabre became a director. NBB
Feb 11, 2008 New establishment in Roeselare. KBO

In short

From € 385,919 profit in 2022 to € 397,576 profit in 2025.

Paid € 714,932 in corporate taxes since 2022.

Best year ever: 2024, with € 623,854 profit.

Paid out € 384,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Gerd Fabre

DR. GERD FABRE

Behind DR. GERD FABRE is Gerd Fabre.

Directors

According to the 2025 annual accounts

Gerd Fabre

Administrator-manager

since 2008

Establishments

Establishment units

Physical locations of this company

Registered office

Terbankstraat 12

3020 Herent

2.303.920.640

Deltalaan 1

8800 Roeselare

Active since 11 February 2008

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Herent

Same main activity (Activiteiten van medisch specialisten), 35 active companies in Herent, largest first.

Dr.Leroux, oogarts - Dr.Ector, cardioloog

€ 1 million gross margin · 2025

Dokter De Blauwe A.,oogarts

€ 588,913 gross margin · 2025

DOKTER THOMAS STEELANDT

€ 547,990 gross margin · 2025

Sara Ombelet

€ 521,885 gross margin · 2025

DR. MATHIEU STRUYVE

€ 474,704 gross margin · 2025

Sofie Odent

€ 410,133 gross margin · 2025

All companies with this activity → Largest companies in Herent →

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

25 February 2008 Source: Deed ↗

FABRÉ Gerd(oprichter-vennoot) 100%

Details

Company number: 0895.712.153
VAT number: BE 0895.712.153
Registered office: Terbankstraat 12, 3020 Herent
Names & denominations: DR. GERD FABRE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 11 February 2008
Peppol: Active · Active since 10 Mar 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗